| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Kelley Kenneth J is a Director at HALOZYME THERAPEUTICS, INC.. Recent SEC Form 4 filings include 3 buys and 13 sells.
Estimated insider holdings value: $12.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2021 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 5,000 | $45.00 | $225,000.00 | -2.7% | -2.3% | -8.0% | |
| Mar 1, 2021 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 5,000 | $45.34 | $226,717.40 | -1.3% | - | - | |
| Feb 1, 2021 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 5,000 | $48.12 | $240,593.95 | -1.3% | - | - | |
| Jan 4, 2021 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 5,000 | $42.91 | $214,555.58 | -1.3% | - | - | |
| Dec 7, 2020 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 35,086 | $41.00 | $1,438,526.00 | -14.9% | - | - | |
| Dec 2, 2020 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 31,792 | $41.00 | $1,303,472.00 | -11.9% | - | - | |
| Nov 27, 2020 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 19,671 | $41.37 | $813,850.37 | -3.5% | - | - | |
| Mar 19, 2020 | HALO Halozyme Therapeutics, Inc. | Director | Buy | 52,629 | $14.23 | $748,696.65 | +7.2% | - | - | |
| Jun 18, 2015 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 20,000 | $21.00 | $420,000.00 | -9.2% | - | - | |
| Mar 5, 2015 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 40,000 | $15.33 | $613,380.00 | -17.0% | - | - |